Перегляд за Автор "Burmak, Y."

Зараз показуємо 1 - 2 з 2
  • Ескіз недоступний
    Документ
    Daily monitoring of arterial pressure as a method of early diagnosis of arterial hypertension in young patients
    (HSEE of Ukraine “Ukrainian Medical Stomatological Academy”, 2018) Ivanytska, T.; Burmak, Y.; Petrov, Ye.; Treumova, S.; Ivanytskyi, I.; Іваницька, Тетяна Анатоліївна; Бурмак, Юрій Григорович; Петров, Євген Євгенович; Треумова, Світлана Іванівна; Іваницький, Ігор Валерійович
    Thus, it can be concluded that daily monitoring of blood pressure is a highly sensitive method that allows diagnosing arterial hypertension in young patients in the early stages. It should be noted that the majority of patients with arterial hypertension had pathological daily profiles, which indicates an unfavorable prognosis and it needs for more careful management of such patients. It seems that we should change our traditional practice to diagnose and manage BP according to office measurements and more broadly use 24-h ABPM, particularly in young patients, to optimize BP control.
  • Ескіз недоступний
    Документ
    Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease
    (Higher State Educational Establishment of Ukraine “Ukrainian Medical Stomatological Academy”, Str. Shevchenka, 23, 36000, Poltava, Ukraine, 2018) Chekalina, N.; Burmak, Y.; Petrov, Ye.; Borisova, Z.; Manusha, Y.; Kazakov, Yu.; Kaidashev, I. P.; Кайдашев, Ігор Петрович; Чекаліна, Наталія Ігорівна; Бурмак, Юрій Григорович; Петров, Євген Євгенович; Борисова, Зінаїда Олексіївна; Мануша, Юлія Іванівна; Казаков, Юрій Михайлович
    The aim of this study was to determine the effect of quercetin on the indicators of chronic systemic inflammation (CSI) in stable coronary artery disease (CAD). Methods: This study included 85 patients with CAD, stable angina pectoris, functional class (FC) II, and heart failure (=F) 0-y. Each patient was prescribed beta-blockers, statins, and aspirin. In addition, a total of 30 patients, forming the study group received quercetin at a daily dose of 120 mg for two months, while the remaining 55 patients made up the control group. The levels of cytokines, such as tumor necrosis factor (TNF-a), interleukin-1b (IL-1b), and interleukin-10 (IL-10) in serum and the expression of the inhibitor of kappa B a (IkBa) gene in blood mononuclear cells, were determined.